← ANALYST RATINGS · TIPRANKS
Compass Therapeutics (CMPX): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Moderate Buy5 Buy2 Hold0 Sell
Ratings of 7 analysts in the last 3 months · top analysts only12-month forecast
$6.40+644.2% upside
Based on 7 price targets given in the last 3 months, the average target is $6.40, the highest $12.00, the lowest $1.00. The average is +644.2% from the last price of $0.86.
Highest target $12.00
Average target $6.40
Lowest target $1.00
Analyst ratings 14
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.84 → $0.86+1.9% | Hold | 0.0% | Upgrade | 17.10.26on TipRanks Oct 16 22:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.83 → $0.84+1.9% | Sell | −2.1% | Reiterated | 17.10.26on TipRanks Oct 16 22:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.84 → $0.86+1.9% | Hold | 0.0% | Reiterated | 17.10.26on TipRanks Oct 16 22:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.80 → $0.82+2.0% | Sell | −4.7% | Reiterated | 17.10.26on TipRanks Oct 16 22:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.83 → $0.85+1.9% | Sell | −1.0% | Reiterated | 17.10.26on TipRanks Oct 16 22:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.83 → $0.85+1.9% | Sell | −1.0% | Downgrade | 17.10.26on TipRanks Oct 16 22:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.82 → $0.84+2.6% | Hold | −1.9% | Upgrade | 15.10.26on TipRanks 16:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.81 → $0.83+2.5% | Sell | −4.0% | Reiterated | 15.10.26on TipRanks 16:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.82 → $0.84+2.6% | Hold | −1.9% | Reiterated | 15.10.26on TipRanks 16:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.78 → $0.80+2.6% | Sell | −6.5% | Reiterated | 15.10.26on TipRanks 16:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.81 → $0.83+2.6% | Sell | −2.9% | Reiterated | 15.10.26on TipRanks 16:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.81 → $0.83+2.6% | Sell | −2.9% | Downgrade | 15.10.26on TipRanks 16:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.92 → $0.82−10.7% | Hold | −4.3% | Upgrade | 14.10.26on TipRanks 10:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.90 → $0.81−10.6% | Sell | −6.3% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.92 → $0.82−10.7% | Hold | −4.3% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.88 → $0.78−10.7% | Sell | −8.8% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.91 → $0.81−10.7% | Sell | −5.3% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.91 → $0.81−10.7% | Sell | −5.3% | Downgrade | 14.10.26on TipRanks 10:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.86 → $0.92+7.7% | Hold | +7.2% | Upgrade | 06.10.26on TipRanks 11:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.85 → $0.90+6.0% | Sell | +4.9% | Reiterated | 06.10.26on TipRanks 11:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $0.87 → $0.92+6.1% | Hold | +7.2% | Reiterated | 06.10.26on TipRanks 11:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.83 → $0.88+5.9% | Sell | +2.1% | Reiterated | 06.10.26on TipRanks 11:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.85 → $0.91+7.7% | Sell | +6.0% | Reiterated | 06.10.26on TipRanks 11:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.86 → $0.91+5.4% | Sell | +6.0% | Downgrade | 06.10.26on TipRanks 11:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $0.99 → $0.86−13.8% | Sell | −0.5% | Downgrade | 02.10.26on TipRanks 05:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $0.98 → $0.85−13.4% | Sell | −1.0% | Reiterated | 02.10.26on TipRanks 05:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $1.00 → $0.87−13.1% | Hold | +1.0% | Reiterated | 02.10.26on TipRanks 05:06 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $0.99 → $0.83−16.1% | Sell | −3.6% | Reiterated | 02.10.26on TipRanks 05:06 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $0.99 → $0.85−14.3% | Sell | −1.5% | Reiterated | 02.10.26on TipRanks 05:06 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $0.99 → $0.86−12.4% | Hold | +0.6% | Upgrade | 02.10.26on TipRanks 05:06 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $1.00 → $0.99−0.7% | Hold | +15.5% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $1.50 → $0.98−34.5% | Sell | +14.3% | Downgrade | 01.10.26on TipRanks 03:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $1.00 | Hold | +16.3% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $1.00 → $0.99−1.2% | Sell | +14.9% | Downgrade | 01.10.26on TipRanks 03:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $1.00 → $0.99−1.2% | Sell | +14.9% | Reiterated | 01.10.26on TipRanks 03:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $1.00 → $0.99−1.2% | Sell | +14.9% | Downgrade | 01.10.26on TipRanks 03:05 | — | |
| Albert Lowe★★★★★★★★★★#3118 · hits 41% · avg +8.2% | Craig-Hallum | $15.00 → $8.00−46.7% | Buy | +830.2% | Reiterated | 23.09.26on TipRanks Sep 24 02:30 | −4.9%next day −2.9% · 5 days −10.4% | ↗ |
| John Newman★★★★★★★★★★#3035 · hits 44% · avg +4.1% | Canaccord Genuity | $7.00 | Buy | +714.0% | Reiterated | 23.09.26on TipRanks 07:15 | −4.9%next day −2.9% · 5 days −10.4% | ↗ |
| Joseph Pantginis★★★★★★★★★★#243 · hits 55% · avg +24.8% | H.C. Wainwright | $24.00 → $12.00−50.0% | Buy | +1,295.3% | Reiterated | 23.09.26on TipRanks 06:12 | −4.9%next day −2.9% · 5 days −10.4% | ↗ |
| Reni Benjamin★★★★★★★★★★#12340 · hits 34% · avg −9.2% | Citizens JMP | $10.00 → $4.00−60.0% | Buy | +365.1% | Reiterated | 23.09.26on TipRanks 05:55 | −4.9%next day −2.9% · 5 days −10.4% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $2.00 → $1.50−25.0% | Hold | +74.4% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $2.00 → $1.50−25.0% | Hold | +74.4% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $2.00 | Hold | +132.6% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $2.00 → $1.50−25.0% | Hold | +74.4% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $2.00 → $1.50−25.0% | Sell | +74.4% | Downgrade | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $2.00 | Hold | +132.6% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| Robert Driscoll★★★★★★★★★★#1346 · hits 46% · avg +10.6% | Wedbush | $5.00 → $1.00−80.0% | Hold | +16.3% | Downgrade | 23.09.26on TipRanks Sep 22 16:25 | −4.9%next day −2.9% · 5 days −10.4% | ↗ |
| Michael Schmidt★★★★★★★★★★#126 · hits 58% · avg +31.7% | Guggenheim | $8.00 → $4.00−50.0% | Buy | +365.1% | Assigned | 22.09.26on TipRanks Sep 23 06:55 | −31.9%next day −4.9% · 5 days −10.1% | ↗ |
| Stephen Willey★★★★★★★★★★#1608 · hits 45% · avg +8.1% | Stifel Nicolaus | — | Buy | — | Reiterated | 22.09.26on TipRanks Sep 23 06:05 | −31.9%next day −4.9% · 5 days −10.1% | ↗ |
| Matt Phipps★★★★★★★★★★#2652 · hits 48% · avg +4.8% | William Blair | — | Buy | — | Reiterated | 22.09.26on TipRanks 15:07 | −31.9%next day −4.9% · 5 days −10.1% | ↗ |
| Charles Zhu★★★★★★★★★★#351 · hits 64% · avg +25.8% | LifeSci Capital | — | Hold | — | Downgrade | 22.09.26on TipRanks 14:35 | −31.9%next day −4.9% · 5 days −10.1% | ↗ |
| Biren Amin★★★★★★★★★★#1671 · hits 46% · avg +7.6% | Piper Sandler | $4.00 → $6.00+50.0% | Buy | +597.7% | Reiterated | 07.08.26on TipRanks 08:01 | +7.4%next day +3.3% · 5 days +4.3% | ↗ |
| Andrew Berens★★★★★★★★★★#336 · hits 49% · avg +24.7% | Leerink Partners | $4.00 → $7.00+75.0% | Buy | +714.0% | Reiterated | 07.08.26on TipRanks 06:55 | +7.4%next day +3.3% · 5 days +4.3% | ↗ |
| Sean McCutcheon★★★★★★★★★★#1382 · hits 43% · avg +39.7% | Raymond James | — | Hold | — | Downgrade | 28.04.26on TipRanks 06:40 | +3.3%next day −9.2% · 5 days +4.3% | ↗ |
| Maury Raycroft★★★★★★★★★★#1326 · hits 44% · avg +12.0% | Jefferies | $9.00 | Buy | +946.5% | Reiterated | 27.04.26on TipRanks 14:10 | −64.6%next day +3.3% · 5 days +8.0% | ↗ |
| Li Watsek★★★★★★★★★★#11877 · hits 39% · avg −9.1% | Cantor Fitzgerald | — | Buy | — | Initiated | 03.12.25on TipRanks 07:30 | +0.8%next day +4.9% · 5 days −1.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Compass Therapeutics
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $6.12 at a price of $1.04 (+488.9%); now: $6.12 at $0.86 (+612.2%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 12 | 7 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 11.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.13 (from $-0.15 to $-0.10). Last quarter: $-0.13.
Best top-analyst consensus in the sector · Healthcare
About Compass Therapeutics
- CEO: Thomas J. Schuetz
- Employees: 39
- 80 Guest Street, Boston, MA, 02135, US
- www.compasstherapeutics.com
Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experimental bispecific antibody engineered to inhibit the Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, both of which are crucial for the growth of new blood vessels and tumor vascularization. Another significant compound is CTX-471, an IgG4 monoclonal antibody that functions as an activator of CD137. Furthermore, their developmental pipeline features CTX-8371, a bispecific inhibitor that targets both PD-1 and PD-L1. The company was established in 2014 and operates from its headquarters in Boston, Massachusetts.
Data from the stock’s TipRanks forecast page, read 48 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗